Table 1 |
|
|
Drugs having 'membrane stabilising activity' with the potential for severe cardiotoxicity depending on dose |
|
|
Anti-arrhythmics class I Vaughan Williams |
Flecainide, disopyramide, cibenzoline, propafenone, quinidine, lidocaine, procainamide |
|
Beta-blockers |
Propranolol, acebutolol, nadoxolol, pindolol, penbutolol, labetalol, oxprenolol |
|
Polycyclic antidepressants |
Imipramine, desipramine, amitritptyline, clomipramine, dosulepin, doxepin, maprotiline |
|
Selective serotonin reuptake inhibitors |
Include venlafaxine, citalopram |
|
Dopamine and norepinephrine uptake inhibitors |
Include bupropion |
|
Anti-epileptics |
Include carbamazepine, phenytoin |
|
Phenothiazines |
Include thioridazine |
|
Opioids |
Include dextropropoxyphene |
|
Antimalarial agents |
Include chloroquine and quinine |
|
Anaesthetic-recreational agents |
Include cocaine |
|
|
|
|
Baud et al. Critical Care 2007 11:207 doi:10.1186/cc5700 |
|